Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics

CL Grek, Z Sheng, CC Naus, WC Sin… - Current opinion in …, 2018 - Elsevier
Highlights•Cx43 regulates invasiveness, proliferation, and resistance of malignant
glioma.•Cx43 provides a permissive niche for the invasion and channel-mediated TMZ …
被引用次数：68 相关文章

Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics

CL Grek, Z Sheng, CC Naus, WC Sin… - Current opinion in …, 2018 - pubmed.ncbi.nlm.nih.gov
Resistance of malignant glioma, including glioblastoma (GBM), to the chemotherapeutic
temozolomide (TMZ) remains a key obstacle in treatment strategies. The gap junction …

Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics.

CL Grek, Z Sheng, CC Naus, WC Sin… - Current Opinion in …, 2018 - europepmc.org
Resistance of malignant glioma, including glioblastoma (GBM), to the chemotherapeutic
temozolomide (TMZ) remains a key obstacle in treatment strategies. The gap junction …
[HTML] nih.gov

[HTML][HTML] Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics

CL Grek, Z Sheng, CC Naus, WC Sin… - Current opinion in …, 2018 - ncbi.nlm.nih.gov
Resistance of malignant glioma, including glioblastoma (GBM), to the chemotherapeutic
temozolomide (TMZ) remains a key obstacle in treatment strategies. The gap junction …

Novel approach to temozolomide resistance in malignant glioma: connexin43-directed therapeutics

CL Grek, Z Sheng, CC Naus, WC Sin… - Current Opinion in …, 2018 - infona.pl
Resistance of malignant glioma, including glioblastoma (GBM), to the chemotherapeutic
temozolomide (TMZ) remains a key obstacle in treatment strategies. The gap junction …